Mengtao Cao

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 2

Top Topics

Atopic Dermatitis

Tyrosine Kinase

Methicillin Resistant Staphylococcus Aureus

Top Venues

The Journal of experimental medicine

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Dongxuan Huang, Pengfei Chen, Guoqing Huang, Huimin Sun, Xiaohua Luo, Chaowen He, Fei Chen, Yong Wang, Changchun Zeng, Lianhui Su, Xiaobin Zeng, Jiachun Lu, Shiyue Li, Dongsheng Huang, Hanchao Gao, Mengtao Cao
Salt-inducible kinases inhibitor HG-9-91-01 targets RIPK3 kinase activity to alleviate necroptosis-mediated inflammatory injury. Cell death & disease 13 (2) (2022)
Siyuan Chen, Fenglin Yun, Yikun Yao, Mengtao Cao, Yifan Zhang, Jingjing Wang, Xinyang Song, Youcun Qian
USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein. The Journal of experimental medicine 215 (11) (2018)